Gainers
- HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.
- Symbotic Inc. (NASDAQ:SYM) shares climbed 76.3% to $16.04. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
- OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) gained 36% to $1.7950 after the company's board approved to upsize its share repurchase program.
- Cyren Ltd. (NASDAQ:CYRN) rose 32.1% to $2.3509 after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure email gateway business.
- Arcellx, Inc. (NASDAQ:ACLX) gained 30.2% to $22.10.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) jumped 26% to $0.3339 after the company announced new SBT-272 data demonstrating improvement in upper motor neuron function in ALS disease model at the Keystone Neurodegeneration Symposium.
- Cidara Therapeutics, Inc. (NASDAQ:CDTX) gained 25.5% to $0.59.
- Exicure, Inc. (NASDAQ:XCUR) shares rose 24.5% to $0.1408 after declining around 6% on Tuesday.
- Qutoutiao Inc. (NASDAQ:QTT) jumped 24.2% to $1.18.
- SQL Technologies Corp. (NASDAQ:SKYX) jumped 23.4% to $2.5799.
- I-Mab (NASDAQ:IMAB) surged 23% to $11.08. I-Mab announced completion of patient enrollment in Phase III clinical trial of eftansomatropin alfa for treatment of pediatric growth hormone deficiency.
- Gaotu Techedu Inc. (NYSE:GOTU) gained 22.5% to $1.9600. Gaotu Techedu recently announced Q1 earnings results.
- 17 Education & Technology Group Inc. (NASDAQ:YQ) gained 22% to $2.9399.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) jumped 20.8% to $0.44.
- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) surged 20.7% to $1.57.
- Annovis Bio, Inc. (NYSE:ANVS) gained 19.9% to $12.95.
- Katapult Holdings, Inc. (NASDAQ:KPLT) rose 19.8% to $1.7250.
- CTI BioPharma Corp. (NASDAQ:CTIC) gained 18% to $6.29.
- Rubius Therapeutics, Inc. (NASDAQ:RUBY) surged 17.9% to $1.25.
- Youdao, Inc. (NYSE:DAO) jumped 17.8% to $6.13.
- Energy Focus, Inc. (NASDAQ:EFOI) shares gained 16.6% to $2.6584 after jumping more than 46% on Tuesday. The company recently announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
- MediciNova, Inc. (NASDAQ:MNOV) surged 16.6% to $2.74. MediciNova said the Phase 2 trial of MN-166 (ibudilast) in hospitalized COVID-19 patients demonstrated significant improvements compared to placebo for all four clinical endpoints analyzed.
- MINISO Group Holding Limited (NYSE:MNSO) jumped 16.4% to $6.33.
- SRAX, Inc. (NASDAQ:SRAX) gained 15.8% to $4.17. SRAX recently reported fourth-quarter FY21 Sequire revenue growth of 170% year-on-year to $9.6 million, missing the consensus of $10.2 million.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 15.7% to $5.73 after reporting Q1 results. Kingsoft Cloud reported first-quarter FY22 revenue growth of 19.9% year-on-year to $342.9 million, beating the consensus of $312.2 million.
- Imperial Petroleum Inc. (NASDAQ:IMPP) rose 14.9% to $0.6777 after gaining more than 9% on Tuesday.
- TAL Education Group (NYSE:TAL) gained 14.9% to $5.24.
- Tiziana Life Sciences Ltd (NASDAQ:TLSA) jumped 13.8% to $0.8336. Tiziana Life Sciences announced second patient showed clinical improvements in the positron emission tomography imaging analysis, neurologic exam, and timed 25-foot walk test, following three months of treatment in secondary progressive multiple sclerosis trial.
- Full Truck Alliance Co. Ltd. (NYSE:YMM) rose 12.2% to $8.94 after reporting Q1 results following Q1 results. The company reported first-quarter revenue of RMB1.33 billion ($210.2 million), up 53.7% year-over-year.
- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) rose 9.2% to $0.2328 after declining 5% on Tuesday.
- Evolve Transition Infrastructure LP (NYSE:SNMP) rose 6.2% to $0.5640 after the company announced court approval of Mesquite Energy, Inc. settlement agreement.
Losers
- Loyalty Ventures Inc. (NASDAQ:LYLT) shares dipped 56.4% to $4.81 after the company said it will reevaluate its 2022 revenue and EBITDA guidance and said its AIR MILES reward program and AIR MILES' sponsor Sobeys were unable to align on extension terms.
- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) dropped 53.5% to $0.8167 after the company announced data from the FORWARD Phase 3 clinical trial did not demonstrate statistical significance in the primary efficacy endpoint.
- Phoenix Motor Inc. (NASDAQ:PEV) fell 38.9% to $4.58. Phoenix Motor priced its initial public offering of 2.1 million shares at $7.50 per share.
- Integrated Media Technology Limited (NASDAQ:IMTE) fell 31.3% to $7.70.
- Cosmos Holdings Inc. (NASDAQ:COSM) dropped 23.3% to $0.82.
- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 16.5% to $0.96.
- AeroClean Technologies, Inc. (NASDAQ:AERC) shares fell 15.4% to $10.24 after jumping 155% on Tuesday. The FDA recently granted clearance for the company's pūrgo technology, classifying it as a class II medical device.
- The Lovesac Company (NASDAQ:LOVE) fell 14.6% to $32.40 after the company reported Q1 financial results.
- The Singing Machine Company, Inc. (NASDAQ:MICS) dropped 14.5% to $3.36.
- Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) declined 14.5% to $41.97 after the company reported a secondary offering of 2,000,000 shares held by Ziff Davis.
- Applied UV, Inc. (NASDAQ:AUVI) shares fell 14.4% to $1.8650 after jumping 96% on Tuesday.
- Cadre Holdings, Inc. (NYSE:CDRE) dropped 14.3% to $23.95. Cadre Holdings announced launch of public primary and secondary offering of 1.75 million of common stock.
- Microvast Holdings, Inc. (NASDAQ:MVST) fell 13.7% to $3.6050.
- Odyssey Marine Exploration, Inc. (NASDAQ:OMEX) declined 13.4% to $2.79.
- HashiCorp, Inc. (NASDAQ:HCP) dropped 12.3% to $33.58.
- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) declined 10.8% to $61.11.
- The Scotts Miracle-Gro Company (NYSE:SMG) fell 9.5% to $92.45 after the company cut its FY22 EPS guidance below analyst estimates.
- Matson, Inc. (NYSE:MATX) fell 9.4% to $85.65.
- Smartsheet Inc. (NYSE:SMAR) shares fell 7.3% to $37.61 after the company issued Q2 adjusted EPS guidance below analyst estimates.
